You are here

Article info

Article menu
Original research
PAX6 is frequently expressed in ependymal tumours and associated with prognostic relevant subgroups

Authors

  • Julian Tabasaran Department of Neuropathology, Institute of Pathology and Neuropathology, University Hospital of Tuebingen, Eberhard Karls University of Tuebingen, Tuebingen, Germany PubMed articlesGoogle scholar articles
  • Martin Schuhmann Department of Neurosurgery, Eberhard Karls University of Tuebingen, Baden-Württemberg, Germany Center for Neuro-Oncology, Comprehensive Cancer Center Tuebingen-Stuttgart, University Hospital of Tuebingen, Eberhard Karls University of Tuebingen, Tuebingen, Germany Division of Pediatric Neurosurgery, Department of Neurosurgery, University Hospital of Tuebingen, Eberhard Karls University of Tuebingen, Tuebingen, Germany PubMed articlesGoogle scholar articles
  • Martin Ebinger Department Pediatric Hematology/Oncology, Children's University Hospital, Eberhard Karls University of Tuebingen, Tuebingen, Germany PubMed articlesGoogle scholar articles
  • Jürgen Honegger Department of Neurosurgery, Eberhard Karls University of Tuebingen, Baden-Württemberg, Germany Center for Neuro-Oncology, Comprehensive Cancer Center Tuebingen-Stuttgart, University Hospital of Tuebingen, Eberhard Karls University of Tuebingen, Tuebingen, Germany PubMed articlesGoogle scholar articles
  • Mirjam Renovanz Department of Neurosurgery, Eberhard Karls University of Tuebingen, Baden-Württemberg, Germany Center for Neuro-Oncology, Comprehensive Cancer Center Tuebingen-Stuttgart, University Hospital of Tuebingen, Eberhard Karls University of Tuebingen, Tuebingen, Germany Interdisciplinary Division of Neuro-Oncology, University Hospital of Tuebingen, Eberhard Karls University of Tuebingen, Tuebingen, Germany PubMed articlesGoogle scholar articles
  • Jens Schittenhelm Department of Neuropathology, Institute of Pathology and Neuropathology, University Hospital of Tuebingen, Eberhard Karls University of Tuebingen, Tuebingen, Germany Center for Neuro-Oncology, Comprehensive Cancer Center Tuebingen-Stuttgart, University Hospital of Tuebingen, Eberhard Karls University of Tuebingen, Tuebingen, Germany PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Jens Schittenhelm, Department of Neuropathology, Eberhard Karls Universitat Tubingen, Tubingen, Baden-Württemberg, Germany; jens.schittenhelm{at}med.uni-tuebingen.de
View Full Text

Citation

Tabasaran J, Schuhmann M, Ebinger M, et al
PAX6 is frequently expressed in ependymal tumours and associated with prognostic relevant subgroups
Journal of Clinical Pathology 2022;75:759-765.

Publication history

  • Received March 4, 2021
  • Accepted May 20, 2021
  • First published June 28, 2021.
Online issue publication 
October 18, 2023

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.